Multicenter phase II study of pre-administered uracil/tegafur (UFT) plus gemcitabine for unresectable/recurrent pancreatic cancer

Shoji Nakamori, Wakio Endo, Hiroki Ozato, Takashi Shibata, Yutaka Takeda, Ken Tohno, Yasunori Hasuike, Seizo Masutani, Takashi Morimoto, Yuichirou Doki, Masaki Mori, Morito Monden

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'Multicenter phase II study of pre-administered uracil/tegafur (UFT) plus gemcitabine for unresectable/recurrent pancreatic cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences